Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma

Clinical trial NCT00049673 · COMPLETED

Trial details

NCT number: NCT00049673
Sponsor: NCIC Clinical Trials Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2002-10-15
Primary completion: 2011-10-19
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.